Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Occidental Petroleum
OXY
5
Louisiana-Pacific
LPX
JP Stock MarketDetailed Quotes
4594 BrightPath Biotherapeutics
- 39
- 00.00%
20min DelayMarket Closed May 9 15:30 JST
3.53BMarket Cap-2.14P/E (Static)
40High38Low400.50KVolume40Open39Pre Close15.64MTurnover8952wk High0.47%Turnover Ratio90.49MShares3252wk Low-16.51EPS TTM3.35BFloat Cap2229Historical HighLossP/E (Static)85.94MShs Float32Historical Low-18.21EPS LYR5.13%Amplitude--Dividend TTM2.79P/B100Lot Size--Div YieldTTM
BrightPath Biotherapeutics Key Stats
BrightPath Biotherapeutics Q4 2025 Earnings Date
Currency：JPYMay 9, 2025
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | -- | 1.00M | -- |
+19900.00% | |||
| EPS | -- | -3.82 | -- |
-24.40% |
Analyst Rating
No Data
BrightPath Biotherapeutics Earnings Estimates
Revenue
EPS
EBIT
No Data
BrightPath Biotherapeutics Earnings Reports
Read more
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve
Buffettttttt
May 3 21:00
Berkshire's 2025 Annual Shareholders Meeting